Sartorius AG Stock Deutsche Boerse AG

Equities

SRT

DE0007165607

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG 02:00:59 2024-05-03 EDT After market 15:59:55
220 EUR -0.23% Intraday chart for Sartorius AG 223 +1.36%

Financials

Sales 2024 * 3.58B 3.85B 5.27B Sales 2025 * 4.02B 4.33B 5.93B Capitalization 17.53B 18.87B 25.82B
Net income 2024 * 214M 230M 315M Net income 2025 * 343M 369M 505M EV / Sales 2024 * 6.03 x
Net Debt 2024 * 4.05B 4.36B 5.97B Net Debt 2025 * 3.82B 4.11B 5.62B EV / Sales 2025 * 5.31 x
P/E ratio 2024 *
77.4 x
P/E ratio 2025 *
52.2 x
Employees 14,614
Yield 2024 *
0.3%
Yield 2025 *
0.4%
Free-Float 35.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.13%
1 week-2.22%
Current month-2.22%
1 month-18.37%
3 months-20.43%
6 months+8.11%
Current year-16.67%
More quotes
1 week
218.00
Extreme 218
228.00
1 month
205.00
Extreme 205
271.50
Current year
205.00
Extreme 205
290.50
1 year
182.60
Extreme 182.6
310.00
3 years
182.60
Extreme 182.6
839.00
5 years
140.00
Extreme 140
839.00
10 years
21.61
Extreme 21.607
839.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 99-04-30
Chief Tech/Sci/R&D Officer 59 94-12-31
Chief Operating Officer 67 00-12-31
Members of the board TitleAgeSince
Director/Board Member 69 19-12-31
Director/Board Member 75 11-11-28
Director/Board Member 58 17-04-05
More insiders
Date Price Change Volume
24-05-03 220 -0.23% 0
24-05-02 220.5 -2.00% 8
24-04-30 225 -0.66% 118
24-04-29 226.5 +4.86% 10
24-04-26 216 -4.00% 0

Delayed Quote Deutsche Boerse AG, May 03, 2024 at 02:00 am

More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
281.5 EUR
Average target price
330.8 EUR
Spread / Average Target
+17.52%
Consensus